Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 189

1.

Cysteine-independent activation/inhibition of heme oxygenase-2.

Vukomanovic D, Rahman MN, Maines MD, Ozolinš TR, Szarek WA, Jia Z, Nakatsu K.

Med Gas Res. 2016 Apr 4;6(1):10-13. eCollection 2016 Mar.

2.
3.

Interaction of human biliverdin reductase with Akt/protein kinase B and phosphatidylinositol-dependent kinase 1 regulates glycogen synthase kinase 3 activity: a novel mechanism of Akt activation.

Miralem T, Lerner-Marmarosh N, Gibbs PE, Jenkins JL, Heimiller C, Maines MD.

FASEB J. 2016 Aug;30(8):2926-44. doi: 10.1096/fj.201600330RR. Epub 2016 May 10.

4.

Biliverdin reductase: a target for cancer therapy?

Gibbs PE, Miralem T, Maines MD.

Front Pharmacol. 2015 Jun 3;6:119. doi: 10.3389/fphar.2015.00119. eCollection 2015. Review.

5.

Human biliverdin reductase-based peptides activate and inhibit glucose uptake through direct interaction with the kinase domain of insulin receptor.

Gibbs PE, Lerner-Marmarosh N, Poulin A, Farah E, Maines MD.

FASEB J. 2014 Jun;28(6):2478-91. doi: 10.1096/fj.13-247015. Epub 2014 Feb 25.

6.

The role of bile pigments in health and disease: effects on cell signaling, cytotoxicity, and cytoprotection.

Kapitulnik J, Maines MD.

Front Pharmacol. 2012 Jul 13;3:136. doi: 10.3389/fphar.2012.00136. eCollection 2012. No abstract available.

7.

The human biliverdin reductase-based peptide fragments and biliverdin regulate protein kinase Cδ activity: the peptides are inhibitors or substrate for the protein kinase C.

Miralem T, Lerner-Marmarosh N, Gibbs PE, Tudor C, Hagen FK, Maines MD.

J Biol Chem. 2012 Jul 13;287(29):24698-712. doi: 10.1074/jbc.M111.326504. Epub 2012 May 14.

8.

Biliverdin reductase: more than a namesake - the reductase, its Peptide fragments, and biliverdin regulate activity of the three classes of protein kinase C.

Gibbs PE, Tudor C, Maines MD.

Front Pharmacol. 2012 Mar 13;3:31. doi: 10.3389/fphar.2012.00031. eCollection 2012.

9.
12.
13.

Human biliverdin reductase suppresses Goodpasture antigen-binding protein (GPBP) kinase activity: the reductase regulates tumor necrosis factor-alpha-NF-kappaB-dependent GPBP expression.

Miralem T, Gibbs PE, Revert F, Saus J, Maines MD.

J Biol Chem. 2010 Apr 23;285(17):12551-8. doi: 10.1074/jbc.M109.032771. Epub 2010 Feb 22.

14.

Pleiotropic functions of biliverdin reductase: cellular signaling and generation of cytoprotective and cytotoxic bilirubin.

Kapitulnik J, Maines MD.

Trends Pharmacol Sci. 2009 Mar;30(3):129-37. doi: 10.1016/j.tips.2008.12.003. Epub 2009 Feb 11. Review.

PMID:
19217170
15.

Human biliverdin reductase is an ERK activator; hBVR is an ERK nuclear transporter and is required for MAPK signaling.

Lerner-Marmarosh N, Miralem T, Gibbs PE, Maines MD.

Proc Natl Acad Sci U S A. 2008 May 13;105(19):6870-5. doi: 10.1073/pnas.0800750105. Epub 2008 May 7.

16.

Biliverdin reductase is a transporter of haem into the nucleus and is essential for regulation of HO-1 gene expression by haematin.

Tudor C, Lerner-Marmarosh N, Engelborghs Y, Gibbs PE, Maines MD.

Biochem J. 2008 Aug 1;413(3):405-16. doi: 10.1042/BJ20080018.

17.

Biliverdin reductase: PKC interaction at the cross-talk of MAPK and PI3K signaling pathways.

Maines MD.

Antioxid Redox Signal. 2007 Dec;9(12):2187-95. Review.

PMID:
17919068
18.
19.

Regulation of TNF-alpha-activated PKC-zeta signaling by the human biliverdin reductase: identification of activating and inhibitory domains of the reductase.

Lerner-Marmarosh N, Miralem T, Gibbs PE, Maines MD.

FASEB J. 2007 Dec;21(14):3949-62. Epub 2007 Jul 17.

PMID:
17639074
20.

Human biliverdin reductase, a previously unknown activator of protein kinase C betaII.

Maines MD, Miralem T, Lerner-Marmarosh N, Shen J, Gibbs PE.

J Biol Chem. 2007 Mar 16;282(11):8110-22. Epub 2007 Jan 16.

21.

Redox regulation of heat shock protein expression by signaling involving nitric oxide and carbon monoxide: relevance to brain aging, neurodegenerative disorders, and longevity.

Calabrese V, Butterfield DA, Scapagnini G, Stella AM, Maines MD.

Antioxid Redox Signal. 2006 Mar-Apr;8(3-4):444-77. Review.

PMID:
16677090
22.

Antiaging medicine: antioxidants and aging.

Calabrese V, Maines MD.

Antioxid Redox Signal. 2006 Mar-Apr;8(3-4):362-4. No abstract available.

PMID:
16677082
23.
24.

The heme oxygenase system: update 2005.

Maines MD.

Antioxid Redox Signal. 2005 Nov-Dec;7(11-12):1761-6. Review. No abstract available.

PMID:
16356137
25.
26.

30 some years of heme oxygenase: from a "molecular wrecking ball" to a "mesmerizing" trigger of cellular events.

Maines MD, Gibbs PE.

Biochem Biophys Res Commun. 2005 Dec 9;338(1):568-77. Epub 2005 Aug 24. Review.

PMID:
16183036
27.

Human biliverdin reductase: a member of the insulin receptor substrate family with serine/threonine/tyrosine kinase activity.

Lerner-Marmarosh N, Shen J, Torno MD, Kravets A, Hu Z, Maines MD.

Proc Natl Acad Sci U S A. 2005 May 17;102(20):7109-14. Epub 2005 May 3.

29.

The heme oxygenase system: past, present, and future.

Maines MD.

Antioxid Redox Signal. 2004 Oct;6(5):797-801. No abstract available.

PMID:
15345138
30.

Biliverdin reductase, a novel regulator for induction of activating transcription factor-2 and heme oxygenase-1.

Kravets A, Hu Z, Miralem T, Torno MD, Maines MD.

J Biol Chem. 2004 May 7;279(19):19916-23. Epub 2004 Feb 25.

32.

Neotrofin increases heme oxygenase-1 selectively in neurons.

Wang X, Hauptmann N, Taylor E, Foreman M, Khawli LA, Maines MD.

Brain Res. 2003 Feb 7;962(1-2):1-14.

PMID:
12543450
33.

Bile pigments: newcomers to the cell signaling arena.

Maines MD.

Toxicol Sci. 2003 Jan;71(1):9-10. Review.

PMID:
12520070
34.

Crystal structure of a biliverdin IXalpha reductase enzyme-cofactor complex.

Whitby FG, Phillips JD, Hill CP, McCoubrey W, Maines MD.

J Mol Biol. 2002 Jun 21;319(5):1199-210.

PMID:
12079357
35.

Heme oxygenase 1 transgenic mice as a model to study neuroprotection.

Maines MD.

Methods Enzymol. 2002;353:374-88.

PMID:
12078511
36.
37.
38.

Heme oxygenase-2 interaction with metalloporphyrins: function of heme regulatory motifs.

Huang TJ, McCoubrey WK Jr, Maines MD.

Antioxid Redox Signal. 2001 Aug;3(4):685-96.

PMID:
11554454
39.

Overview of heme degradation pathway.

Maines MD.

Curr Protoc Toxicol. 2001 May;Chapter 9:Unit 9.1. doi: 10.1002/0471140856.tx0901s00. Review.

PMID:
23045067
40.

Human biliverdin reductase is autophosphorylated, and phosphorylation is required for bilirubin formation.

Salim M, Brown-Kipphut BA, Maines MD.

J Biol Chem. 2001 Apr 6;276(14):10929-34. Epub 2001 Jan 17.

42.

Nuclear localization of biliverdin reductase in the rat kidney: response to nephrotoxins that induce heme oxygenase-1.

Maines MD, Ewing JF, Huang TJ, Panahian N.

J Pharmacol Exp Ther. 2001 Mar;296(3):1091-7.

PMID:
11181945
43.

Assessment of induction of biliverdin reductase in a mouse model of middle cerebral artery occlusion.

Panahian N, Maines MD.

Brain Res Brain Res Protoc. 2000 Nov;6(1-2):53-70.

PMID:
11086264
44.

Nitric oxide induces heme oxygenase-1 via mitogen-activated protein kinases ERK and p38.

Chen K, Maines MD.

Cell Mol Biol (Noisy-le-grand). 2000 May;46(3):609-17.

PMID:
10872747
45.

The heme oxygenase system and its functions in the brain.

Maines MD.

Cell Mol Biol (Noisy-le-grand). 2000 May;46(3):573-85. Review.

PMID:
10872744
46.

Neurons overexpressing heme oxygenase-1 resist oxidative stress-mediated cell death.

Chen K, Gunter K, Maines MD.

J Neurochem. 2000 Jul;75(1):304-13.

47.
50.

The oxidoreductase, biliverdin reductase, is induced in human renal carcinoma--pH and cofactor-specific increase in activity.

Maines MD, Mayer RD, Erturk E, Huang TJ, Disantagnese A.

J Urol. 1999 Oct;162(4):1467-72.

PMID:
10492239

Supplemental Content

Loading ...
Support Center